Kootte et al. found that the improvement of insulin sensitivity in MetS patients in the lean donor group infused with lean donors after FMT may be related to the post-transplantation intestinal growth of the butyric acid-producing bacterium Roseburia byresteria growth (33). Here, INS is linked to metabolic syndrome.